The EFPIA made the comments in a conference call with the commission that included representatives from European companies including Bayer, Fresenius, Gedeon, Ipsen Chiesi, Novartis, and Sanofi.

Located on the outskirts of the historic Italian city – home to Verdi and myriad architectural gems – the press launch and tour of the €85 million Chiesi development was a quintessentially ...

A statement from the commission said Novo Nordisk, Novartis, Fresenius, Sanofi, Bayer, Gedeon Richter and Ipsen Chiesi attended the call. Further, the statement said the industry raised "strong ...

Among those at the meeting: Bayer AG, Chiesi, Novartis, Novo Nordisk, Sanofi, the European Confederation of Pharmaceutical Entrepreneurs and the European Federation of Pharmaceutical Industries and ...

A statement from the commission said Novo Nordisk, Novartis, Fresenius, Sanofi, Bayer, Gedeon Richter and Ipsen Chiesi attended the call. Further, the statement said the industry raised "strong ...

A statement from the commission said Novo Nordisk, Novartis, Fresenius, Sanofi, Bayer, Gedeon Richter and Ipsen Chiesi attended the call. Further, the statement said the industry raised "strong ...

The overall incidence of colorectal cancer (CRC) in the United Kingdom plateaued at 67.4 per 100,000 person-years from 2000 to 2021, with slight improvements observed in overall survival ...

Please provide your email address to receive an email when new articles are posted on . Camlipixant is a P2X3 antagonist. Studied patients had a baseline awake cough frequency of at least 25 ...

This list is current as of: 2025-03-31. An Excel version of the updated SUR List is available from the Overview page.

Italian biopharma Chiesi Group has announced a major investment in Nerviano, near Milan, with the building of a new facility for the production of its therapeutic solutions. The project entails the ...